Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.

Søren Gullaksen Liv VernstrømSteffen S SørensenSteffen Ringgaard Christoffer Laustsen Kristian Løkke Funck Per Løgstrup Poulsen Esben Laugesen

Published in: Diabetologia (2023)

Clinicaltrialsregister.eu EudraCT 2019-000781-38 FUNDING: Novo Nordisk Foundation, Central Denmark Region Research Fund and Danish Medical Associations Research Foundation.

Keyphrases

healthcare
health insurance
study protocol
open label
contrast enhanced
blood flow
clinical trial